Eunji Sung
Psychiatric/Mental Health · Suwanee, GANPI 1821455783
Payments from drug & device makers
Across 208 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$637
- Supernus Pharmaceuticals, Inc.$381
- Novo Nordisk$300
- Amarin Pharma, Inc.$292
- Otsuka America Pharmaceutical, Inc.$227
- AstraZeneca$199
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,060100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $637 |
| Supernus Pharmaceuticals, Inc. | 7 | $381 |
| Novo Nordisk | 13 | $300 |
| Amarin Pharma, Inc. | 18 | $292 |
| Otsuka America Pharmaceutical, Inc. | 7 | $227 |
| AstraZeneca | 7 | $199 |
| Lundbeck LLC | 8 | $184 |
| Sanofi-aventis U.S. LLC | 9 | $180 |
| Bayer | 4 | $172 |
| Amgen | 9 | $142 |
| Lilly USA, LLC | 8 | $139 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $121 |
| Dexcom, Inc. | 7 | $117 |
| Pfizer | 5 | $104 |
| Johnson & Johnson(2 entities) | 5 | $83 |
| Medtronic | 3 | $81 |
| GSK | 4 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
| Vivus LLC | 4 | $60 |
| Tris Pharma Inc | 3 | $55 |
| Corium, LLC | 5 | $43 |
| VBI Vaccine (delaware) Inc. | 2 | $38 |
| Astellas Pharma US Inc | 2 | $33 |
| Neos Therapeutics, LP | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Merck | 2 | $26 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Scilex Pharmaceuticals Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $24 |
| ITF Therapeutics LLC | 1 | $23 |
| Radius Health, Inc. | 1 | $22 |
| Ironshore Pharmaceuticals Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
| Gilead | 1 | $16 |
| Insulet Corporation | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,060 in reported general payments places this provider in the 90th percentile of 900 psychiatric/mental health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 29 | $22,018 |
| VascepaIcosapent Ethyl | 23 | $21,159 |
| ProliaDenosumab | 11 | $19,141 |
| JardianceEmpagliflozin | 11 | $14,932 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $9,565 |
| Diclofenac Sodium | 14 | $641 |
| Atorvastatin Calcium | 89 | $348 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $326 |
| Pravastatin Sodium | 36 | $282 |
| Losartan Potassium | 57 | $242 |
| Metformin Hcl | 75 | $232 |
| Fluticasone Propionate | 12 | $211 |
| Tamsulosin Hcl | 32 | $207 |
| Levothyroxine Sodium | 20 | $154 |
| Amlodipine Besylate | 42 | $150 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $199 | $22,01829 claims |
| AmgenProlia | $142 | $19,14111 claims |
| Boehringer IngelheimJardiance | $18 | $14,93211 claims |
| GSKTrelegy Ellipta | $78 | $9,56515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 900 psychiatric/mental health providers in Georgia.
Other psychiatric/mental health in Suwanee
- Bradley MosherSuwanee$13K
- Mia MisonSuwanee$12K
- Susan LangSuwanee$8K
- Veronica Ndegwa-GibbonsSuwanee$5K
- Candace TrippeSuwanee$5K
- Allison AndresonSuwanee$5K
- Phuong-Tuyen leSuwanee$5K
- Phyillis Kennedy-HowellBarney$673K
- Jessica OliverThomasville$233K
- Sherri KrollBrunswick$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.